News Onconetix, Inc.

Equities

ONCO

US09610B1089

End-of-day quote Nasdaq Other stock markets 03:30:00 15/05/2024 am IST			5-day change	1st Jan Change
0.1116 ^USD	+0.36%		+0.63%	-43.64%

11/04	Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
13/02	Onconetix, Inc. Announces Appointment of Ajit Singh to its Board of Directors	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Immunovia Publishes Interim Report for January-March 2024	29/04	AQ
Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12/04	CI
Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors	13/02	AQ
Onconetix, Inc. Announces Appointment of Ajit Singh to its Board of Directors	13/02	CI
Onconetix, Inc. Appoints Thomas Meier to the Board of Directors	13/02	CI
Nasdaq Stocks Under $1 to Watch Now! VTAK, IVP, ONCO, AKTS, RDHL	31/01	AQ
Wall Street Set to Open Marginally Lower Friday; December Inflation Data Lower Than Forecast	26/01	MT
US Futures Nudge Lower in Friday's Premarket Ahead of Fed Inflation Data	26/01	MT
Onconetix, Inc. announced that it has received $5 million in funding	23/01	CI
Onconetix, Inc. Announces Chief Executive Officer Changes	13/01	CI
Onconetix, Inc. Announces Executive Changes	13/01	CI
Onconetix, Inc. Announces Resignation of Erin Henderson as Chief Business Officer	29/12	CI
Onconetix, Inc.(NasdaqCM:ONCO) added to NASDAQ Composite Index	26/12	CI
Onconetix, Inc. Announces Executive Appointments	22/12	CI
Onconetix, Inc.(NasdaqCM:ONCO) dropped from NASDAQ Composite Index	21/12	CI
Blue Water Biotech, Inc. acquired ProteoMediX AG for $51.9 million.	21/12	CI
Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders	19/12	AQ
Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™	18/12	AQ
Blue Water Biotech, Inc has Changed its Name to Onconetix, Inc	15/12	CI
Tranche Update on Blue Water Biotech, Inc.'s Equity Buyback Plan announced on November 10, 2022.	18/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Onconetix, Inc.

Equities

ONCO

US09610B1089

Summary

Filters